362 related articles for article (PubMed ID: 33092505)
1. Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
Luo X; Xue X; Li T; Zhang Y; Huang L; Cheng G
Curr Drug Metab; 2020; 21(13):1022-1030. PubMed ID: 33092505
[TBL] [Abstract][Full Text] [Related]
2. Potential interactions between triazole antifungal agents and lorlatinib based on ultra-performance liquid chromatography-tandem mass spectrometry in rat plasma.
Ye Z; Wang C; Li R; Chen C; Yang J; Chen Y; Fu J; Zhou T; Jin M; Huang A; Zhang X; Zhou Z
J Pharm Pharmacol; 2024 Jan; 76(2):115-121. PubMed ID: 38150242
[TBL] [Abstract][Full Text] [Related]
3. Physiologically based pharmacokinetic modeling and simulation to predict drug-drug interactions of ivosidenib with CYP3A perpetrators in patients with acute myeloid leukemia.
Prakash C; Fan B; Ke A; Le K; Yang H
Cancer Chemother Pharmacol; 2020 Nov; 86(5):619-632. PubMed ID: 32978634
[TBL] [Abstract][Full Text] [Related]
4. Triazole Antifungal Quantification for Therapeutic Drug Monitoring in Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Posaconazole, Voriconazole, Itraconazole, and Hydroxyitraconazole.
Girton M; Tomsig J; Bazydlo L
Methods Mol Biol; 2024; 2737():55-65. PubMed ID: 38036810
[TBL] [Abstract][Full Text] [Related]
5. Effects of the CYP3A inhibitors, voriconazole, itraconazole, and fluconazole on the pharmacokinetics of osimertinib in rats.
Lou Y; Song F; Cheng M; Hu Y; Chai Y; Hu Q; Wang Q; Zhou H; Bao M; Gu J; Zhang Y
PeerJ; 2023; 11():e15844. PubMed ID: 37581117
[TBL] [Abstract][Full Text] [Related]
6. Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.
Krishna G; Moton A; Ma L; Savant I; Martinho M; Seiberling M; McLeod J
Clin Ther; 2009 Feb; 31(2):286-98. PubMed ID: 19302901
[TBL] [Abstract][Full Text] [Related]
7. Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease Interactions.
Ono C; Hsyu PH; Abbas R; Loi CM; Yamazaki S
Drug Metab Dispos; 2017 Apr; 45(4):390-398. PubMed ID: 28167538
[TBL] [Abstract][Full Text] [Related]
8. Effects of CYP3A inhibitors on the pharmacokinetics of quizartinib, a potent and selective FLT3 inhibitor, and its active metabolite.
Li J; Kankam M; Trone D; Gammon G
Br J Clin Pharmacol; 2019 Sep; 85(9):2108-2117. PubMed ID: 31173645
[TBL] [Abstract][Full Text] [Related]
9. Effects of ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of apatinib in rats.
Lou D; Cui X; Bao SS; Sun W; Pan WH; Chen MC; Dong YY; Hu GX; Chen RJ; Wang Z
Drug Dev Ind Pharm; 2019 Apr; 45(4):689-693. PubMed ID: 30632818
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic interaction study of combining imatinib with dasatinib in rats by UPLC-MS/MS.
Zhou Y; Wang S; Ding T; Wu M; Geng P; Zhang Q; Ma J
Drug Dev Ind Pharm; 2015; 41(12):1948-53. PubMed ID: 25632980
[TBL] [Abstract][Full Text] [Related]
11. Reliable and Easy-To-Use Liquid Chromatography-Tandem Mass Spectrometry Method for Simultaneous Analysis of Fluconazole, Isavuconazole, Itraconazole, Hydroxy-Itraconazole, Posaconazole, and Voriconazole in Human Plasma and Serum.
Müller C; Gehlen D; Blaich C; Prozeller D; Liss B; Streichert T; Wiesen MHJ
Ther Drug Monit; 2017 Oct; 39(5):505-513. PubMed ID: 28742650
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of voriconazole, posaconazole, itraconazole and hydroxy-itraconazole in human plasma using LCMS/MS.
Jenkins N; Black M; Schneider HG
Clin Biochem; 2018 Mar; 53():110-115. PubMed ID: 29325818
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of ketoconazole, itraconazole and voriconazole on the pharmacokinetics of imatinib and its main metabolite GCP74588 in rat.
Lin G; Wang C; Qiu X; Wang Z; Han A; Xu T; Kan X; Hu G
Drug Dev Ind Pharm; 2014 Dec; 40(12):1616-22. PubMed ID: 24053419
[TBL] [Abstract][Full Text] [Related]
14. Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population.
Salerno SN; Carreño FO; Edginton AN; Cohen-Wolkowiez M; Gonzalez D
Drug Metab Dispos; 2021 Sep; 49(9):844-855. PubMed ID: 34154994
[TBL] [Abstract][Full Text] [Related]
15. Development of a liquid chromatography tandem mass spectrometry method for the simultaneous measurement of voriconazole, posaconazole and itraconazole.
Wadsworth JM; Milan AM; Anson J; Davison AS
Ann Clin Biochem; 2017 Nov; 54(6):686-695. PubMed ID: 27941128
[TBL] [Abstract][Full Text] [Related]
16. Corneal Pharmacokinetics of Voriconazole and Posaconazole following Intrastromal Injection and Posaconazole Eye Drops Instillation in Rats.
Gueudry J; Le Goff L; Lamoureux F; Pereira T; Levefre S; Razakandrainibe R; Costa D; Ballet JJ; Muraine M; Favennec L
Curr Eye Res; 2020 Nov; 45(11):1369-1372. PubMed ID: 32228098
[No Abstract] [Full Text] [Related]
17. Development of UPLC-MS/MS Method for Studying the Pharmacokinetic Interaction Between Dasatinib and Posaconazole in Rats.
Yang S; Zhang X; Wang Y; Wen C; Wang C; Zhou Z; Lin G
Drug Des Devel Ther; 2021; 15():2171-2178. PubMed ID: 34079220
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of ketoconazole and voriconazole on the pharmacokinetics of carvedilol in rats.
Wang L; Wang S; Chen M; Chen X; Lin Y; Hu X; Huang X; Li X; Hu G
Drug Dev Ind Pharm; 2015; 41(10):1661-6. PubMed ID: 25417773
[TBL] [Abstract][Full Text] [Related]
19. Effects of CYP3A inhibitors ketoconazole, voriconazole, and itraconazole on the pharmacokinetics of sunitinib and its main metabolite in rats.
Wang J; Cui X; Cheng C; Wang Y; Sun W; Huang CK; Chen RJ; Wang Z
Chem Biol Interact; 2021 Apr; 338():109426. PubMed ID: 33617800
[TBL] [Abstract][Full Text] [Related]
20. Validation of a fast and reliable liquid chromatography-tandem mass spectrometry (LC-MS/MS) with atmospheric pressure chemical ionization method for simultaneous quantitation of voriconazole, itraconazole and its active metabolite hydroxyitraconazole in human plasma.
Xiong X; Zhai S; Duan J
Clin Chem Lab Med; 2013 Feb; 51(2):339-46. PubMed ID: 23095205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
